A

P17-16 EdelweissPredict – A framework and workflow for integrated analysis supporting prediction of drug adverse outcomes demonstrated on a case study for the drug pair troglitazone and rosiglitazone

Toxicology Letters, vol. 368, pp. S232–S233

Authors 7

  1. Edelweiss Connect (Switzerland)

    Affiliation as printed

    Edelweiss Connect GmbH, Basel, Switzerland

  2. Edelweiss Connect (Switzerland)

    Affiliation as printed

    Edelweiss Connect GmbH, Basel, Switzerland

  3. Edelweiss Connect (Switzerland)

    Affiliation as printed

    Edelweiss Connect GmbH, Basel, Switzerland

  4. B. ter Braak Aachen

    Leiden University

    Affiliation as printed

    University of Leiden, Leiden, Netherlands

  5. Affiliation as printed

    SBX Technologies, Tokyo, Japan

  6. Affiliation as printed

    SBX Technologies, Tokyo, Japan

  7. Edelweiss Connect (Switzerland)

    Affiliation as printed

    Edelweiss Connect GmbH, Basel, Switzerland

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-11).

References 0